Editorial, By Zsofia K. Stadler, MD; Deborah Schrag, MD, MPH; EMBARGOED FOR RELEASE: 4 P.M. (ET), MONDAY, JUNE 5, 2023 Approximately 10% of patients diagnosed with cancer have a germline variant in a gene that increases susceptibility to cancer.1 The most common examples include germline pathogenic variants (mutations) in BRCA1 and BRCA2, which are associated […]
Read more of this post
No comments:
Post a Comment